Wu, M., Fulgenzi, C. A. M., D’Alessio, A., Cortellini, A., Celsa, C., Manfredi, G. F., Stefanini, B., Wu, Y. L., Huang, Y.-H., Saeed, A., Pirozzi, A., Pressiani, T., Rimassa, L., Schoenlein, M., Schulze, K., von Felden, J., Mohamed, Y., Kaseb, A. O., Vogel, A., … Ang, C. (2025). Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab. JHEP Reports, 7(2), 101232. https://doi.org/10.1016/j.jhepr.2024.101232

Agarwal, H., Wang, Y., Tinsley, B., Wang, X., & Ozcan, L. (2025). RAP1A suppresses hepatic steatosis by regulating amino acid-mediated mTORC1 activation. JHEP Reports, 7(4), 101303. https://doi.org/10.1016/j.jhepr.2024.101303

Shi, H., Moore, M. P., Wang, X., & Tabas, I. (2024). Efferocytosis in liver disease. JHEP Reports, 6(1), 100960. https://doi.org/10.1016/j.jhepr.2023.100960

Thompson, R. J., Artan, R., Baumann, U., Calvo, P. L., Czubkowski, P., Dalgic, B., D’Antiga, L., Di Giorgio, A., Durmaz, Ö., Gonzalès, E., Grammatikopoulos, T., Gupte, G., Hardikar, W., Houwen, R. H. J., Kamath, B. M., Karpen, S. J., Lacaille, F., Lachaux, A., Lainka, E., … Kjems, L. (2023). Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis. JHEP Reports, 5(8), 100782. https://doi.org/10.1016/j.jhepr.2023.100782

Moore, M. P., Wang, X., Shi, H., Meroni, M., Cherubini, A., Ronzoni, L., Parks, E. J., Ibdah, J. A., Rector, R. S., Valenti, L., Dongiovanni, P., & Tabas, I. (2023). Circulating indian hedgehog is a marker of the hepatocyte-TAZ pathway in experimental NASH and is elevated in humans with NASH. JHEP Reports, 5(5), 100716. https://doi.org/10.1016/j.jhepr.2023.100716

Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022). Understanding the cellular interactome of non-alcoholic fatty liver disease. JHEP Reports, 4(8), 100524. https://doi.org/10.1016/j.jhepr.2022.100524

Wu, H.-C., Jeng, W.-J., Pan, M.-H., Hsieh, Y.-C., Lu, S.-N., Chen, C.-J., & Yang, H.-I. (2022). Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection. JHEP Reports, 4(2), 100410. https://doi.org/10.1016/j.jhepr.2021.100410